Date: 2025/05/27 - 22:32
"Japanese walking" is a low impact exercise protocol that may help improve cardiometabolic health. Also known as interval walking training (IWT), this low-impact workout is accessible to people of all ages and fitness levels.
Date: 2025/05/20 - 19:31
A secondary heart attack could be prevented by replacing 30 minutes of sedentary behavior with light-intensity or moderate-to-vigorous-intensity physical activity, or even with sleep.
Date: 2025/05/19 - 22:32
Tirzepatide (Zepbound) led to more weight loss than semaglutide (Wegovy) in a clinical trial funded by Eli Lilly. Participants who received tirzepatide also had greater improvements in metabolic risk factors. Tirzepatide's dual effects on GLP-1 and GIP may explain its superior performance.
Date: 2025/05/18 - 16:31
Semaglutide, available under the brand names Ozempic and Wegovy, may help decrease the risk of major adverse cardiovascular events after just six months of starting the medication, a new study indicates.
Date: 2025/05/15 - 23:32
Federal regulators have accepted Novo Nordisk’s application to produce a pill version of its injectable weight-loss medication Wegovy. Experts say an oral medication for weight loss might be more cost effective and easier for people to use.